Amanda L Wilkins

ORCID: 0000-0002-4265-1966
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antimicrobial Resistance in Staphylococcus
  • Influenza Virus Research Studies
  • Pneumonia and Respiratory Infections
  • Pharmaceutical studies and practices
  • Immunotherapy and Immune Responses
  • Food Allergy and Anaphylaxis Research
  • Neonatal and Maternal Infections
  • Insects and Parasite Interactions
  • Immune responses and vaccinations
  • Autoimmune Neurological Disorders and Treatments
  • Global Maternal and Child Health
  • Immune Response and Inflammation
  • Antibiotics Pharmacokinetics and Efficacy
  • Streptococcal Infections and Treatments
  • NMR spectroscopy and applications
  • Respiratory and Cough-Related Research
  • Calcium signaling and nucleotide metabolism
  • Dermatological diseases and infestations
  • Bacterial Infections and Vaccines
  • Respiratory viral infections research
  • Drug-Induced Adverse Reactions
  • Cytomegalovirus and herpesvirus research
  • Rabies epidemiology and control

Royal Children's Hospital
2017-2025

Murdoch Children's Research Institute
2023-2025

The University of Melbourne
2023-2025

Oxford BioMedica (United Kingdom)
2017-2023

University of Oxford
2017-2023

Oxford University Hospitals NHS Trust
2017

Frenchay Hospital
2011

University of Bristol
2011

North Bristol NHS Trust
2011

Many standard intermittent dosing regimens for vancomycin in infants fail to achieve the therapeutic target at steady state. This study used population pharmacokinetic (popPK) modelling and simulation determine an optimized regimen, clinically evaluated this regimen aged 0-90 days. An model-based AUC24 of 400-650 mg/L·h was developed from a published popPK model. The PTA achieving as well trough concentration 10-20 mg/L (still commonly clinical practice surrogate AUC24) determined....

10.1093/jac/dkaf112 article EN PubMed 2025-04-04

The pediatric population receives the majority of vaccines globally, yet there is a paucity studies on transcriptional response induced by immunization in this special population. In study, we performed systems-level analysis immune responses to trivalent inactivated influenza vaccine adjuvanted with MF-59 children (15-24 months old) and young, healthy adults. We analyzed elicited vaccination peripheral blood, as well cellular antibody following primary booster vaccinations. Our revealed...

10.1038/s41541-023-00702-1 article EN cc-by npj Vaccines 2023-07-13

Objective Beta-lactam antibiotic allergies are reported in 5%–10% of children; however, up to 90% do not have any reaction at oral challenge test (OCT). This study aimed determine the frequency and identify predictors positive in-hospital graded beta-lactam OCTs children with a allergy label (AAL). Design is retrospective conducted over 7 years, including aged 0–19 years who underwent OCT. The OCT comprised an followed by 5-day outpatient course. Univariate multivariate logistic regression...

10.1136/archdischild-2024-327036 article EN Archives of Disease in Childhood 2024-07-30
Coming Soon ...